Norepinephrine bitartrate and Ventricular tachycardia - a phase IV clinical study of FDA data

Summary:

Ventricular tachycardia is reported as a side effect among people who take Norepinephrine bitartrate (norepinephrine bitartrate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Propofol, and have Hypotension.

The phase IV clinical study analyzes which people have Ventricular tachycardia when taking Norepinephrine bitartrate. It is created by eHealthMe based on reports of 2,366 people who have side effects when taking Norepinephrine bitartrate from the FDA, and is updated regularly.

What is Norepinephrine bitartrate?

Norepinephrine bitartrate has active ingredients of norepinephrine bitartrate. eHealthMe is studying from 2,370 Norepinephrine bitartrate users. Check the latest studies of Norepinephrine bitartrate.

What is Ventricular tachycardia?

Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart) is found to be associated with 1,281 drugs and 2,098 conditions by eHealthMe. Check the latest studies of Ventricular tachycardia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

2,366 people reported to have side effects when taking Norepinephrine bitartrate.
Among them, 44 people (1.86%) have Ventricular tachycardia.

Could Norepinephrine bitartrate cause Ventricular tachycardia?

Among these 44 people:

How long have people been on Norepinephrine bitartrate when they have Ventricular tachycardia? *

  • < 1 month: 83.33 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 16.67 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Ventricular tachycardia when taking Norepinephrine bitartrate? *

  • female: 41.67 %
  • male: 58.33 %

What is the age of people who have Ventricular tachycardia when taking Norepinephrine bitartrate? *

  • 0-1: 2.86 %
  • 2-9: 0.0 %
  • 10-19: 5.71 %
  • 20-29: 5.71 %
  • 30-39: 11.43 %
  • 40-49: 8.57 %
  • 50-59: 14.29 %
  • 60+: 51.43 %

What are other drugs people take besides Norepinephrine bitartrate? *

  1. Propofol: 11 people, 25.00%
  2. Lasix: 8 people, 18.18%
  3. Nitroglycerin: 7 people, 15.91%
  4. Coreg: 6 people, 13.64%
  5. Fentanyl: 5 people, 11.36%
  6. Morphine: 5 people, 11.36%
  7. Pantoprazole: 5 people, 11.36%
  8. Hydrocortisone: 5 people, 11.36%
  9. Vasopressin: 4 people, 9.09%
  10. Morphine Sulfate: 4 people, 9.09%

What are other side effects people have besides Ventricular tachycardia? *

  1. Hypotension (abnormally low blood pressure): 11 people, 25.00%
  2. Cardiac Arrest: 8 people, 18.18%
  3. Ventricular Fibrillation (abnormally irregular heart rhythm): 8 people, 18.18%
  4. Sepsis (a severe blood infection that can lead to organ failure and death): 7 people, 15.91%
  5. Acute Kidney Failure: 5 people, 11.36%
  6. Drug Ineffective: 5 people, 11.36%
  7. Cardiogenic Shock (inadequate circulation of blood): 5 people, 11.36%
  8. Dyspnea (difficult or laboured breathing): 5 people, 11.36%
  9. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 11.36%
  10. Cardiac Failure: 4 people, 9.09%

What are the existing conditions these people have? *

  1. Hypotension (abnormally low blood pressure): 5 people, 11.36%
  2. Anaesthesia: 4 people, 9.09%
  3. Septic Shock (shock due to blood infection): 3 people, 6.82%
  4. Nausea (feeling of having an urge to vomit): 2 people, 4.55%
  5. Arteriospasm Coronary (spasm of the large- or medium-sized coronary arteries): 2 people, 4.55%
  6. Sedation: 2 people, 4.55%
  7. Respiratory Disorder (respiratory disease): 2 people, 4.55%
  8. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 4.55%
  9. Pneumonia: 2 people, 4.55%
  10. Pain In Extremity: 2 people, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Norepinephrine bitartrate and have Ventricular tachycardia?

- Check whether Ventricular tachycardia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Norepinephrine bitartrate:

Ventricular tachycardia treatments and more:

How severe was Ventricular tachycardia and when was it recovered:

Expand to all the drugs that have ingredients of norepinephrine bitartrate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Norepinephrine bitartrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ventricular tachycardia:

Browse all the conditions that are associated with Ventricular tachycardia:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on norepinephrine bitartrate (the active ingredients of Norepinephrine bitartrate) and Norepinephrine bitartrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: